TGFB1 and medulloblastoma: Pathways identified within subgroups were largely signaling pathways including TGF-β, neurotrophic receptors, and NOTCH, which are known to impact prognosis in medulloblastoma and according to our findings may vary by sex within subgroups (34, 47, 48).